Cardiopulmonary nerve stimulation as a novel therapy for cardiac autonomic nervous system modulation

31 January 2024, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.

Abstract

Acute decompensated heart failure (ADHF) carries a significant burden of mortality and morbidity, 30 with few effective treatments available. Cardiopulmonary nerve stimulation (CPNS), which involves targeted electrical stimulation of specific nerves that innervate the heart, is an innovative emerging therapeutic ADHF management strategy. In a recent study, Emani et al. used the CPNS using a low-level stimulation which enhanced cardiac inotropy, decreased energy consumption, and improved patients’ symptoms, function, and quality of life. The mechanism of action of CPNS that drove these promising results was not described by Emani et al. This commentary aims to explore the mechanisms of CPNS, focusing on its neuromodulatory effects on the cardiac autonomic nervous system (CANS) and its potential to revolutionize ADHF therapy.

Keywords

Cardiac Autonomic Nervous System
Heart Failure
Cardiopulmonary nerve stimulation
Afferent and Efferent cardiac nerves
Autonomic imbalance
Neuromodulation

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.